Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Ashley Croft

Nurse Practitioner, Psychiatric/Mental Health Caldwell, ID Nurse Practitioner

NPI 1316311954 CMS profile 10837924

2609 S 10Th Ave, Caldwell, ID 83605

Open in the dashboard

General payments

$12,760

393 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ashley Croft of Caldwell, ID is reported in the CMS Open Payments database as having received $12,760 across 393 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Nurse Practitioner, Psychiatric/Mental Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,096 110
2024 General $1,566 92
2023 General $1,253 78
2022 General $3,756 70
2021 General $4,089 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ashley Croft
  • Nurse Practitioner, Psychiatric/Mental Health median
  • Middle half of Nurse Practitioner, Psychiatric/Mental Health
  • National median

In program year 2025, general payments to Ashley Croft were reported at $2,096. Among 26,152 Nurse Practitioner, Psychiatric/Mental Health profiles paid that year, the median was $258 and the middle half received between $93 and $764.

Show as a table
Year Ashley Croft Nurse Practitioner, Psychiatric/Mental Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $4,089 $166 $54–$482 $132
2022 $3,756 $195 $66–$559 $149
2023 $1,253 $233 $82–$673 $160
2024 $1,566 $236 $84–$688 $164
2025 $2,096 $258 $93–$764 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Allergan Inc. $5,194 9 payments
  2. AbbVie, Inc. $1,781 141 payments
  3. Alkermes, Inc. $1,055 36 payments
  4. Merz North America, Inc. $596 7 payments
  5. Supernus Pharmaceuticals, Inc. $453 27 payments
  6. ITI, Inc. $433 20 payments
  7. E.R. Squibb & Sons, L.L.C. $430 10 payments
  8. Neuronetics, Inc. $377 6 payments
  9. Ironshore Pharmaceuticals Inc. $338 21 payments
  10. Corium, Inc. $325 24 payments
  11. Other $1,779 92 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $7,556 384 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,150 7 payments
  3. Education $54 2 payments
Products named General payments · program years 2021–2025
  1. VRAYLAR $937 73 payments
  2. LYBALVI $555 26 payments
  3. VIVITROL $479 9 payments
  4. ARISTADA Cns $408 23 payments
  5. ARISTADA Cns $408 23 payments
  6. COBENFY $401 9 payments
  7. QELBREE $335 24 payments
  8. ARISTADA Cns $334 18 payments
  9. ARISTADA Cns $334 18 payments
  10. UBRELVY $327 18 payments
  11. Other $5,125 257 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

393 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Psychiatric/Mental Health in Idaho

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record